2016년 주요 연사
Amer Alghabban, MSc Pharmacol., Vice President, GxP Quality Assurance, Compliance and Training, Research & Development, Karyopharm Therapeutics, Inc.
Patrick Baeuerle, Ph.D., Managing Director, MPM Capital
Inpyo Choi, Ph.D., Director, Immunotherapy Convergence Center, Korea Research Institute of Bioscience & Biotechnology
Daniel Christ, Ph.D., Associate Professor and Director, Centre for Targeted Therapy, Immunology Program, Garvan Institute of Medical Research
Dimiter Dimitrov, Ph.D., Senior Investigator, Cancer Inflammation Program, National Cancer Institute, NIH
Jonathan M. Gershoni, Ph.D., Professor, Cell Research and Immunology, Tel Aviv University
Rui Gong, Ph.D., Professor & Head, Antibody Engineering Group, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences
Philip Gotwals, Ph.D., Executive Director, Exploratory Immuno-Oncology, Novartis Institutes of Biomedical Research
Felix Hart, Scientist, Preclinical Pharmacology & ADCs, Glycotope GmbH
Peer Heine, Ph.D., Field Application Scientist, Research & Development, MaxCyte
Sean Hu, Ph.D., Founder, Dophen Biomed
Tomoyuki Igawa, Ph.D., Head of Biologics Discovery, Research Division, Chugai Pharmaceutical Co., Ltd.
Yong-Sung Kim, Ph.D., Professor, Molecular Science & Technology, Ajou University
Bong-Kook Ko, Ph.D., Deputy Director, Antibody Therapeutic Research Center, AbClon, Inc.
Sukmook Lee, Ph.D., Principal Investigator, Research Center, Scripps Korea Antibody Institute
Hyung-Kwon (Harry) Lim, Ph.D., Antibody Engineering, Mogam Biotechnology Institute
Ji-Young Min, Ph.D., Principal Investigator, Head, Respiratory Viruses Research Laboratory, Discovery Biology Department, Institute Pasteur Korea
Julia Neugebauer, Ph.D., Assistant Director, Discovery, Alliances & Technologies, Morphosys AG
Bruce Nianhe Han, Ph.D., CSO, NewBio Therapeutics
Johan Nilvebrant, Ph.D., Researcher, Protein Technology, Royal Institute of Technology
Keiya Ozawa, M.D., Ph.D., Director, IMSUT Hospital, Director, Center for Gene & Cell Therapy, Professor, Division of Genetic Therapeutics, University of Tokyo
Sofie Pattijn, CTO, ImmunXperts
Jonas Schaefer, Ph.D., Head, High-Throughput Binder Selection Facility, Department of Biochemistry, University of Zurich
Jieyi Wang, Ph.D., Senior Principal Scientist, Oncology Biologics, AbbVie
Young Woo Park, Ph.D., CEO, Y Biologics
Chengbin Wu, Ph.D., CEO, EpimAb Biotherapeutics
William R. Strohl, Ph.D., Vice President and Biologics Fellow, Janssen Research & Development, LLC
Weikang Tao, Ph.D., Vice President & CEO, R&D Center, Jiangsu Hengrui Medicine Co., Ltd.
Kye Sook Yi, Ph.D., Senior Manager and Team Leader, New Antibody Development, R&D, Celltrion
Tianlei Ying, Ph.D., Professor, Antibody Engineering and Drug Discovery Group, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences,
Fudan University, China
Jin-San Yoo, Ph.D., CEO, President and Founder, PharmAbcine
Paul Youm, J.D., Legal Counsel, SillaJen, Inc.
Zhenping Zhu, M.D., Ph.D., Executive Vice President, Global Biologics R&D, Kadmon Corporation, LLC